Target intelligence / Profile preview

Colonization factor antigen 6 (CS6)

Target
CS6
Molecular classification
Other (bacterial adhesin protein complex), Non-fimbrial colonization factor, Chaperone-usher (CU) pathway-assembled heteropolyadhesin
01

Overview

Colonization factor antigen 6 (CS6) is a widely expressed surface organelle of enterotoxigenic *Escherichia coli*. CS6 is a heteropolymeric adhesin composed of two subunits, CssA and CssB, which are alternately assembled into linear fibers on the bacterial surface via the chaperone-usher pathway[1][2][6]. CS6 facilitates high-affinity attachment of bacteria to the small intestinal epithelium through binding to host cell receptors, including fibronectin and the glycosphingolipid sulfatide, enabling ETEC colonization and subsequent delivery of diarrheagenic toxins[1][3][4]. CS6 is distinct from most ETEC colonization factors in that it is non-fimbrial, and its molecular assembly and receptor interactions have been elucidated through structural and binding studies[1][2][3][4]. Because it is crucial for ETEC pathogenicity, CS6 is under investigation as a vaccine antigen and a therapeutic target for preventing diarrheal diseases caused by ETEC[1][4][6].

Other names
CS6Coli surface antigen 6
02

Mechanism of action

For potential therapies: inhibition of bacterial adhesion to the gut epithelium by blocking CS6-receptor interactions, neutralization by antibodies, vaccine-induced immune response

03

Biological functions

Adhesion to small intestinal epithelial cellsPolyvalent binding to host cell surface receptors, including fibronectin and sulfatideMediates ETEC colonization as a prerequisite for toxin delivery
04

Disease associations

Infection (specifically enterotoxigenic *E. coli*-mediated diarrhea)
05

Safety considerations

Targeting CS6 exclusively may not protect against all ETEC strains, since multiple colonization factors are often involvedPotential for immune evasion due to antigenic variation in ETEC
06

Interacting drugs

None approved, but CS6 is a target for vaccine development and neutralizing monoclonal antibodies in experimental settings
07

Biomarkers

Presence of CS6 in ETEC strains used to identify virulent pathogens and monitor infectionExpression of CS6 in stool or isolates considered a marker of infection

Beyond the preview

Go deeper on Colonization factor antigen 6 (CS6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonization factor antigen 6 (CS6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call